Updated results from a phase I study of nivolumab (nivo) in combination with ipilimumab (ipi) in metastatic renal cell carcinoma (mRCC): The CheckMate 016 study Meeting Abstract
| Authors: | Hammers, H.; Plimack, E. R.; Infante, J. R.; Rini, B. I.; McDermott, D.; Lewis, L.; Voss, M. H.; Sharma, P.; Pal, S. K.; Razak, A.; Kollmannsberger, C. K.; Heng, D.; Spratlin, J.; McHenry, B.; Gagnier, P.; Amin, A. |
| Abstract Title: | Updated results from a phase I study of nivolumab (nivo) in combination with ipilimumab (ipi) in metastatic renal cell carcinoma (mRCC): The CheckMate 016 study |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi364 |
| Language: | English |
| ACCESSION: | WOS:000393913000156 |
| DOI: | 10.1093/annonc/mdw378.16 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1062P -- Source: Wos |
